Anti-GRIA3/ GLUR-C/ GLUR-K3 monoclonal antibody

Anti-GRIA3/ GLUR-C/ GLUR-K3 antibody for FACS & in-vivo assay

Target products collectionGo to GRIA3/GRIA3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T62391-Ab-1/ GM-Tg-hg-T62391-Ab-2Anti-Human GRIA3 monoclonal antibodyHuman
GM-Tg-rg-T62391-Ab-1/ GM-Tg-rg-T62391-Ab-2Anti-Rat GRIA3 monoclonal antibodyRat
GM-Tg-mg-T62391-Ab-1/ GM-Tg-mg-T62391-Ab-2Anti-Mouse GRIA3 monoclonal antibodyMouse
GM-Tg-cynog-T62391-Ab-1/ GM-Tg-cynog-T62391-Ab-2Anti-Cynomolgus/ Rhesus macaque GRIA3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T62391-Ab-1/ GM-Tg-felg-T62391-Ab-2Anti-Feline GRIA3 monoclonal antibodyFeline
GM-Tg-cang-T62391-Ab-1/ GM-Tg-cang-T62391-Ab-2Anti-Canine GRIA3 monoclonal antibodyCanine
GM-Tg-bovg-T62391-Ab-1/ GM-Tg-bovg-T62391-Ab-2Anti-Bovine GRIA3 monoclonal antibodyBovine
GM-Tg-equg-T62391-Ab-1/ GM-Tg-equg-T62391-Ab-2Anti-Equine GRIA3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T62391-Ab-1/ GM-Tg-hg-T62391-Ab-2; GM-Tg-rg-T62391-Ab-1/ GM-Tg-rg-T62391-Ab-2;
GM-Tg-mg-T62391-Ab-1/ GM-Tg-mg-T62391-Ab-2; GM-Tg-cynog-T62391-Ab-1/ GM-Tg-cynog-T62391-Ab-2;
GM-Tg-felg-T62391-Ab-1/ GM-Tg-felg-T62391-Ab-2; GM-Tg-cang-T62391-Ab-1/ GM-Tg-cang-T62391-Ab-2;
GM-Tg-bovg-T62391-Ab-1/ GM-Tg-bovg-T62391-Ab-2; GM-Tg-equg-T62391-Ab-1/ GM-Tg-equg-T62391-Ab-2
Products NameAnti-GRIA3 monoclonal antibody
Formatmab
Target NameGRIA3
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GRIA3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GRIA3/ GLUR-C/ GLUR-K3 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLV000719house mouse Gria3 Lentivirus plasmid
    ORF Viral VectorvGMLV000719house mouse Gria3 Lentivirus particle


    Target information

    Target IDGM-T62391
    Target NameGRIA3
    Gene ID2892,53623,29628,698396,492110,101089925,534626,100055136
    Gene Symbol and Synonyms2900064I19Rik,GluA3,Glur-3,GLUR-C,GLUR-K3,GLUR3,Gluralpha3,GLURC,GRIA3,iGluR3,MRX94,MRXSW
    Uniprot AccessionP42263,P19492
    Uniprot Entry NameGRIA3_HUMAN,GRIA3_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000125675
    Target ClassificationN/A

    The target: GRIA3, gene name: GRIA3, also named as GLUR-C, GLUR-K3, GLUR3, GLURC, GluA3, MRX94. Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing at this locus results in different isoforms, which may vary in their signal transduction properties. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.